Health Product InfoWatch, April 2026
Safety brief: Falsely elevated digoxin levels; Product monograph update: Taro-Melphalan
Monthly update to the Canada Vigilance adverse reaction online database
The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to December 31, 2025. The next update of data is scheduled for early May, 2026.
Health Promotion and Chronic Disease Prevention in Canada, Vol 46, No 4, April 2026
A mixed-methods approach to understanding pharmacistsâ experiences with the CANRISK diabetes risk questionnaire and user guide; Evolving influence of mental health stigma in Ontario public safety organizations: a qualitative study
Health Promotion and Chronic Disease Prevention in Canada, Vol 46, No 4, April 2026
A mixed-methods approach to understanding pharmacistsâ experiences with the CANRISK diabetes risk questionnaire and user guide; Evolving influence of mental health stigma in Ontario public safety organizations: a qualitative study
Health Promotion and Chronic Disease Prevention in Canada, Vol 46, No 3, March 2026
Natural experiments in the built environment: evaluating impacts on health; Shaping healthier futures: community-level impact of the Alberta Healthy Communities Approach